AI Science Tracker
EN

Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, China

1 discovery from 2026

Discoveries

Ensemble machine learning prioritized a candidate pathway tested in mouse and cell models of intestinal injury

Source check: Source checked. Not independent scientific confirmation.

Finding: Ensemble machine-learning analysis prioritized candidate genes for follow-up in mouse and cell models of intestinal ischemia–reperfusion injury. Experimental findings support a candidate protective pathway, but datasets were small and the mechanism needs independent validation; no clinical efficacy is established.

Technology: Ensemble machine-learning analysis prioritized candidate genes and a pathway from transcriptomic datasets for experimental investigation.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Ensemble machine-learning analysis prioritized candidate genes and a pathway from transcriptomic datasets for experimental investigation.
Test and result
Mouse and cell models provided experimental follow-up of machine-learning-prioritized candidates; the paper notes small datasets and need for independent validation.
Limitation / still unknown
Preclinical results do not establish human efficacy; pathway claims require independent validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1966534/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary full-text review as recorded in case evidence; record-level claim and attribution review..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.